SHC NASDAQ Week ended 18 Sep 2026

Weekly Investor Report

Sotera Health Co · Healthcare · Diagnostics & Research

Open interactive chart View report data
Latest close 18.73 USD
2.0% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 12.9% above the Trend Line and sits at 83.4% of its 52-week range. The latest completed week returned 2.0%, after a -4.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is volatility with 52/100 conviction, while the latest news-sentiment score is 58/100. Near-term considerations: earnings are due in 44d.

Setup score 52 out of 100
Latest Close 18.73 USD 18 Sep 2026
1W Return 2.0% latest completed week
4W Return -4.3% short-term follow-through
12W Return 7.8% quarterly tape
Trend Breadth 57.7% 30 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • The trend backdrop is active with a 7-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 4 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.0% Latest completed week; four-week move -4.3%. Indicator stack 56/59 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 52/100 conviction; expected move 7.7%. News sentiment 58/100 12 relevant articles in the latest sentiment read. Event risk 44d Next report is scheduled for 03 Nov 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 12.9% above the Trend Line and sits at 83.4% of its 52-week range. The latest completed week returned 2.0%, after a -4.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug 14 Aug 21 Aug 28 Aug 4 Sep 11 Sep 18 Sep
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9012-week average 0.60

12-week confirmation

Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.90Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers

No recent accumulation markers. 4 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.3% over four weeks, 7.8% over 12 weeks, and 19.8% over one year. The current trend has remained active for 7 consecutive weeks.

Performance by holding period

1W2.0%
4W-4.3%
12W7.8%
26W38.7%
52W19.8%
Active trend streak7 weeks
Active weeks in one year30
Trend breadth57.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.67Latest activity-pressure read.
Pressure change-42.5%Four-week change in activity pressure.
Leadership0.32Latest relative-leadership reading.
RS change-94.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 11 Sep 2026 Financial statements through 30 Jun 2026 Field coverage 94% Model confidence 94%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength50/100Blend of value, momentum, and quality. Underlying universe rank 51; rank 1 is best.
Value19/100Relative valuation strength. Underlying universe rank 82; rank 1 is best.
Quality87/100Profitability and accounting quality. Underlying universe rank 14; rank 1 is best.
Momentum71/100Medium-term price momentum. Underlying universe rank 30; rank 1 is best.
Growth91/100Revenue and earnings growth. Underlying universe rank 10; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework60/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
32.1x
Price divided by trailing earnings.
Price / sales
4.3x
Market value relative to trailing revenue.
EV / EBITDA
13.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
1.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
54.7%
Gross profit retained from each unit of revenue.
Operating margin
36.2%
Operating profit retained from revenue.
Free-cash-flow margin
9.3%
Free cash flow generated from revenue.
Return on invested capital
10.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
8.1%
Latest one-year revenue growth.
EPS growth
580.5%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
1.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

SHC shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.00, expected move of 7.7%, and Sharemaestro trend signal active.

Conviction52/100
Expected move7.7%
Put/call volume0.00
Pressure100
Speculation4
Volatility87
Trend agreement0
Open options detail
Insider activity13 / 7

13 acquisitions and 7 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment58/100

Weighted news tone is positive across 12 relevant articles.

4 positive · 7 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings44dNext report is scheduled for 03 Nov 2026; event risk rises as the date approaches.
Options expected move7.7%Nearest-chain priced movement where available.
52-week drawdown-5.6%Distance below the 52-week high.
13-week volatility3.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+13.9%Week of 3 Apr.
Worst week-4.4%Week of 24 Apr.
Latest week+2.0%Week of 18 Sep.

Shape of recent returns

Strong gains4
Modest gains10
Flat weeks0
Modest losses11
Sharp losses1
Recent vol3.7%13-week weekly-return volatility.
Base vol4.4%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew3.9% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape52/100

Trend, activity pressure, participation, and risk combine to a 52/100 tape read.

 Indicator analysis60/100

Latest 12-week confirmation: trend 7/12, activity pressure 12/12, relative leadership 5/12.

Activity pressure 0.90; 4 reversal markers Factors56/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 62; Small Cap Core rank 93 SVQF60/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 291.5 of 725 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options35/100

SHC shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.00, expected move of 7.7%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 7.7% Sentiment58/100

Weighted news tone is positive across 12 relevant articles.

Sotera Health: Pricing Power And Recurring Revenues Are Growth Drivers (NASDAQ:SHC) Insiders13 / 7

13 acquisitions and 7 disposals in the latest 180-day insider tape.

 Earnings44d

Next report is scheduled for 03 Nov 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
18 Sep 202618.73 USD2.0%16.60 USD14.61 USD0.670.3214.6MOn
11 Sep 202618.37 USD-2.8%16.56 USD14.59 USD0.88-0.727.1MOn
4 Sep 202618.90 USD-1.9%16.51 USD14.57 USD1.071.438.6MOn
28 Aug 202619.27 USD-1.5%16.48 USD14.54 USD1.173.718.8MOn
21 Aug 202619.57 USD3.6%16.44 USD14.52 USD1.175.6118.6MOn
14 Aug 202618.89 USD0.2%16.40 USD14.50 USD0.96-0.6213.0MOn
7 Aug 202618.86 USD5.6%16.41 USD14.48 USD0.920.2216.1MOn
31 Jul 202617.86 USD2.9%16.42 USD14.47 USD0.91-0.1415.3MOff
24 Jul 202617.35 USD-2.3%16.42 USD14.47 USD0.90-2.0415.7MOff
17 Jul 202617.75 USD-3.6%16.43 USD14.48 USD0.95-1.1214.5MOff
10 Jul 202618.42 USD2.7%16.41 USD14.48 USD0.83-1.2414.2MOff
3 Jul 202617.93 USD3.2%16.36 USD14.49 USD0.69-1.8310.7MOff
26 Jun 202617.38 USD9.9%16.32 USD14.49 USD0.50-3.7314.9MOff
19 Jun 202615.82 USD-2.3%16.32 USD14.50 USD0.26-16.079.9MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context